Could cause temporary or reversible harm; serious harm is unlikely.
Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was found out of the specification at 24-month stability interval during Long term stability (25¿C/60%RH).
| Brand name | TRAMADOL HYDROCHLORIDE |
| Generic name | TRAMADOL HYDROCHLORIDE |
| Active ingredient(s) | TRAMADOL HYDROCHLORIDE |
| Distributed by / for | Amneal Pharmaceuticals LLC, Glasgow, KY 42141 |
| NDC | 60219-2348-5 |
| Full product label | traMADol Hydrochloride Tablets, USP, 50 mg, 500-count bottles, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382220, India, Distributed by: Amneal Pharmaceuticals LLC, Glasgow, KY 42141, NDC 60219-2348-5. |
| Recalling firm | Amneal Pharmaceuticals, LLC |
| Distribution | Nationwide within the USA |
| Quantity | 29,542 bottles |
| Recall initiated | 2026-03-19 |
| Report date | 2026-04-08 |
| Recall completed | — |
| Recall number | D-0408-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Bridgewater NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗